CenterWatch and TrialX hope to boost recruitment via web 2.0

By Gareth Macdonald

- Last updated on GMT

A new partnership between CenterWatch and TrialX may help boost flagging recruitment rates by “helping patients more easily and rapidly connect with relevant clinical trials.”

Despite efforts to increase the number of participants through greater use of electronic data capture (EDC) and distribution systems, contract research organisations (CRO) continue to identify patient recruitment and retention as the key bottlenecks in the trial process.

While EDC and protocol improvements can help recruitment rates by making it easier for subjects to participate, such measures do not address the need to increase awareness among patients and physicians of precisely which clinical programmes are available.

It is just this issue that the partnership is designed to address. Under the new three-year deal CenterWatch will share its extensive database of clinical trials with health IT specialist TrialX for inclusion on its website.

TrialX’ site is a suite of web 2.0 services that provide information on trials via a range of outlets that include social media sites like twitter, portals such as Google Health and Microsoft Health Vault as well as a soon to be released iPhone application.

CenterWatch’s senior vice president, Chris Pooley, explained that the rationale for the project is to boost the number of patients participating in clinical trials by increasing the awareness of the programmes available.

"One of CenterWatch's fundamental objectives is to ensure that patients have the access they need to the thousands of clinical trials going on around the world​," adding that "likewise, it's important that investigators have as many avenues as possible for patient recruitment​.”

TrialX’ co-founder, Vivek Garg, was also positive about the collaboration’s ability to improve the flow of information about available clinical trials, providing pharma sponsors with larger patient pools and patients with greater access to new drugs.

Garg suggested that: "This agreement will allow our site to receive current, accurate clinical trials information which will ultimately support our mission to help patients find trials that match their health conditions in an easy and timely manner."

TrialX’ website can be accessed here​.

Related news

Show more

Related products

VDS groß

Meet the challenges of complex injectables

Vetter Pharma International GmbH | 07-Nov-2017 | Technical / White Paper

In the time it takes from the exciting discovery phase to the rigorous demands of a commercial launch, unexpected scientific and technical challenges can...

lyo_vials

Process Development for Lyophilized Products

Baxter BioPharma Solutions | 30-Oct-2017 | Application Note

Baxter approaches formulation and process development with the intention of identifying the failure points for the product. Knowing where the product fails...

Ocopeptides

Advancing therapeutics for myeloma

Recipharm AB | 04-Sep-2017 | Case Study

Multiple myeloma is the second most common blood cancer in the world and despite survival rates increasing over the last decade, there remains a requirement...

Related suppliers